Whole-body medical imaging analysis
Be an early applicant
Whole-body medical imaging analysis
101-200 employees
Be an early applicant
101-200 employees
To transform healthcare and improve human lives through AI-guided precision solutions.
Quibim develops quantitative biomarkers, companion diagnostics and other imaging tools for systems biology applications, from immuno-oncology to neurology. Specialising in advanced whole-body medical imaging, the company’s innovative AI-guided image analysis unlocks imaging data that enables doctors to make the best value-based care decisions for their patients.
The company’s algorithms find abnormalities and biomarkers in X-rays, CT scans, and PET scans to detect disease early. The company leads real-world evidence (RWE) projects with over 10 million de-identified research imaging registries from 50,000+ oncology patients.
Its also reached a significant milestone with its QP-Prostate software, earning FDA 150(k) clearance, UKCA certification, and a CE mark, further solidifying its position in the market. Coupled with a successful Series A funding round, the company is now ready to expand its presence in the US while continuing to build on its success in Europe. With these accomplish,nets, Quibim is in a position for even greater growth and innovation in the future.

Freddie
Company Specialist at Welcome to the Jungle
Jan 2025
$50m
SERIES A
Nov 2021
$5.9m
SEED
Mestalla, València, Spain
Dr. Ángel Alberich-Bayarri
(Co-Founder & CEO)Previously spent nearly 7 years at Quirónsalud as a Research Engineer, R&D Scientific Coordinator and Biomedical Engineering Coordinator.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
